BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2020
View Archived Issues
Ovarian organoids implicate oviducts
Read More
iPSC microtissue gives clues to heart disease
Read More
Estrogen and dopamine
Read More
Identification of a JAK inhibitor selectively targeting GI tissues for inflammatory bowel disease
Read More
A new ASK1 inhibitor presenting brain penetration
Read More
FDA accepts IND for phase I/II trial of Treadwell's HPK1 inhibitor CFI-402411
Read More
Brukinsa receives approval in China for patients with CLL/SLL and MCL
Read More
First patient data presented for PF-06804103 antibody-drug conjugate
Read More
Rgenix presents monotherapy dose-escalation data from phase I study of RGX-202
Read More
Phase II data reported from TreeTopp study of varlitinib plus capecitabine in BTC
Read More
FDA gives FSD Pharma permission to submit IND for phase IIa trial of FSD-201 for COVID-19
Read More
Ube Industries discloses cyclin-dependent kinase 7 inhibitors
Read More
Shanghai Ennova Biopharmaceutical patents neurotrophic tyrosine kinase receptor inhibitors
Read More
New MAP4K1 inhibitors discovered at Pfizer
Read More
New monobactam compounds presented by Nanjing Sanhome Pharmaceutical
Read More
Idorsia Pharmaceuticals identifies new Ox1-R and Ox2-R antagonists
Read More
Data questions arise for two major COVID-19 studies
Read More
Kezar reports updated phase Ib findings on KZR-616 in SLE
Read More
Maxinovel studies MAX-10181 for advanced solid tumors in first-in-human trial
Read More
Kadmon begins first-in-human study of KD-033 in metastatic or locally advanced solid tumors
Read More
European approval for Braftovi with cetuximab for BRAF V600E-mutant metastatic colorectal cancer
Read More
ImmuneOncia begins first-in-human study of IMC-002 for advanced solid tumors and lymphomas
Read More
Phase II dose defined in trial of CBL-0137 in patients with solid tumors
Read More
Pilot study evaluates DNAJB1-PRKACA peptide vaccine for fibrolamellar hepatocellular carcinoma
Read More